Carters vs Gildan Activewear
CRI and GIL side by side, both in apparel and other finished products made from fabrics and similar materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRI and GIL compare
Gildan Activewear grew revenue faster over the last twelve months (10.7% versus 5.0% for Carters).
Gildan Activewear keeps more of each dollar of sales as profit, with a net margin of 11.0% compared with 7.4% at Carters.
Carters pays a dividend yielding 2.9%; Gildan Activewear does not pay one.
Carters scores higher on the StockData Score (21 against 6 for Gildan Activewear), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRI | GIL |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | – |
| Share price | $34.29 | $34.66 |
| Change, 1 year | 3.3% | −40.8% |
| Change, 5 years | −67.9% | −17.4% |
| Beta (5Y) | 0.93 | 0.96 |
| Employees | 15K | 53K |
| StockData Score | ||
| Total score | 21 (better) | 6 |
| Valuation score | 6 (better) | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 5 (better) | 3 |
| Health score | 4 (better) | 1 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 5.7× | – |
| P/S | 0.4× | – |
| P/B | 1.2× | – |
| EV/EBITDA | 3.6× | – |
| P/FCF | 3.9× | – |
| FCF yield | 25.4% | – |
| Fair value | $79.70 | – |
| Margin of safety | 57.0% | – |
| Growth | ||
| Revenue growth (TTM) | 5.0% | 10.7% (better) |
| Revenue growth, 5Y average | −0.85% | 12.8% (better) |
| Net income growth (TTM) | 147% (better) | −0.50% |
| EPS growth (TTM) | 145% (better) | 6.1% |
| EPS growth, 5Y average | 0.24% | – |
| Profitability | ||
| Gross margin | 49.1% (better) | 31.2% |
| Operating margin | 10.4% | 17.1% (better) |
| Net margin | 7.4% | 11.0% (better) |
| FCF margin | 10.7% | 13.8% (better) |
| Return on equity | 22.9% (better) | 15.9% |
| Return on invested capital | 21.3% (better) | 9.9% |
| Financial health | ||
| Debt / equity | 0.54 (better) | 1.21 |
| Net debt / EBITDA | 0.12 (better) | 5.25 |
| Interest coverage | 6.7× | – |
| Current ratio | 2.78 (better) | 2.11 |
| Altman Z-score | 2.93 | – |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.9% | – |
| Payout ratio | 16.6% | 33.9% |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 20.9% | – |
| Shareholder yield | 2.9% | – |
| Ownership | ||
| Held by institutions | 107% | 88.9% |
| Held by insiders | 3.6% | 3.8% |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 17.6% | 6.8% |
Go deeper
- CRI stock overview
- CRI income statement
- CRI valuation and score
- GIL stock overview
- GIL income statement
- GIL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.